Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 66.79% is in line with its 5-year average of 65.43%, around the middle of its 5-year range (60.07%–71.23%).
0.32% below its 12-month average of 67.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-28): 66.44%.
GROSS MARGIN
66.79%
GROSS MARGIN AVG TTM
67.00%
GROSS MARGIN AVG 3Y
65.08%
GROSS MARGIN AVG 5Y
65.43%
GROSS MARGIN AVG 10Y
67.26%
GROSS MARGIN AVG 15Y
67.44%
GROSS MARGIN AVG 20Y
67.14%
CURRENT VS TTM AVG
-0.32%
CURRENT VS 3Y AVG
+2.63%
CURRENT VS 5Y AVG
+2.07%
CURRENT VS 10Y AVG
-0.70%
CURRENT VS 15Y AVG
-0.96%
CURRENT VS 20Y AVG
-0.52%
SECTOR MEDIAN · HEALTHCARE
59.92%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+11.46%
vs the sector median at left
Market Cap
$40.89B
Gross Margin
62.45%
TTM Avg
61.42%
3Y Avg
60.55%
5Y Avg
59.83%
Market Cap
$41.75B
Gross Margin
50.78%
TTM Avg
58.60%
3Y Avg
58.69%
5Y Avg
58.45%
Market Cap
$42.50B
Gross Margin
26.23%
TTM Avg
30.59%
3Y Avg
32.75%
5Y Avg
33.07%
Market Cap
$46.04B
Gross Margin
52.47%
TTM Avg
50.27%
3Y Avg
48.88%
5Y Avg
48.29%
Market Cap
$47.38B
Gross Margin
53.73%
TTM Avg
53.36%
3Y Avg
52.95%
5Y Avg
53.14%
Market Cap
$48.72B
Gross Margin
46.12%
TTM Avg
45.33%
3Y Avg
44.44%
5Y Avg
44.19%
Market Cap
$49.03B
Gross Margin
77.98%
TTM Avg
78.79%
3Y Avg
78.80%
5Y Avg
77.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Illumina, Inc. (ILMN) | $41.31B | 66.79% | 67.00% | 65.08% | 65.43% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.89B | 62.45% | 61.42% | 60.55% | 59.83% |
| Waters Corporation (WAT)vs › | $41.75B | 50.78% | 58.60% | 58.69% | 58.45% |
| IQVIA Holdings Inc. (IQV)vs › | $42.50B | 26.23% | 30.59% | 32.75% | 33.07% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 52.47% | 50.27% | 48.88% | 48.29% |
| Humana Inc. (HUM)vs › | $46.63B | 13.65% | 14.54% | 16.14% | 17.03% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 53.73% | 53.36% | 52.95% | 53.14% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 46.12% | 45.33% | 44.44% | 44.19% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 77.98% | 78.79% | 78.80% | 77.78% |
| Biogen Inc. (BIIB)vs › | $32.49B | 67.71% | 73.30% | 74.61% | 77.63% |
Gross Margin
66.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-28 | 66.44% |
| 2026-03-29 | 66.09% |
| 2025-12-28 | 67.07% |
| 2025-09-28 | 67.59% |
| 2025-06-29 | 67.83% |
| 2025-03-30 | 65.80% |
| 2024-12-29 | 65.94% |
| 2024-09-29 | 68.98% |
| 2024-06-30 | 64.84% |
| 2024-03-31 | 61.99% |
| 2023-12-31 | 60.07% |
| 2023-10-01 | 61.13% |
| 2023-07-02 | 62.24% |
| 2023-04-02 | 60.26% |
| 2022-12-31 | 62.05% |
| 2022-10-02 | 64.30% |
| 2022-07-03 | 66.01% |
| 2022-04-03 | 66.64% |
| 2021-12-31 | 68.14% |
| 2021-10-03 | 69.49% |
| 2021-07-04 | 71.23% |
| 2021-04-04 | 69.90% |
| 2020-12-31 | 66.11% |
| 2020-09-27 | 66.25% |
| 2020-06-28 | 67.61% |
| 2020-03-29 | 72.06% |
| 2019-12-31 | 69.54% |
| 2019-09-29 | 71.44% |
| 2019-06-30 | 68.38% |
| 2019-03-31 | 69.03% |
| 2018-12-31 | 68.05% |
| 2018-09-30 | 69.99% |
| 2018-07-01 | 69.28% |
| 2018-04-01 | 68.80% |
| 2017-12-31 | 69.67% |
| 2017-10-01 | 67.51% |
| 2017-07-02 | 65.56% |
| 2017-04-02 | 61.54% |
| 2016-12-31 | 67.72% |
| 2016-10-02 | 70.17% |
| 2016-07-03 | 70.65% |
| 2016-04-03 | 69.43% |
| 2015-12-31 | 69.37% |
| 2015-09-27 | 70.43% |
| 2015-06-28 | 69.78% |
| 2015-03-29 | 69.63% |
| 2014-12-31 | 75.13% |
| 2014-09-28 | 69.48% |
| 2014-06-29 | 67.15% |
| 2014-03-30 | 66.14% |
| 2013-12-31 | 66.93% |
| 2013-09-29 | 58.84% |
| 2013-06-30 | 64.55% |
| 2013-03-31 | 66.26% |
| 2012-12-31 | 65.85% |
| 2012-09-30 | 68.52% |
| 2012-07-01 | 68.78% |
| 2012-04-01 | 66.36% |
| 2011-12-31 | 68.22% |
| 2011-10-02 | 66.72% |
| 2011-07-03 | 67.27% |
| 2011-04-03 | 66.56% |
| 2010-12-31 | 66.56% |
| 2010-10-03 | 66.22% |
| 2010-07-04 | 68.91% |
| 2010-04-04 | 68.80% |
| 2009-12-31 | 70.44% |
| 2009-09-27 | 67.65% |
| 2009-06-28 | 68.77% |
| 2009-03-29 | 66.40% |
| 2008-12-31 | 66.04% |
| 2008-09-28 | 63.78% |
| 2008-06-29 | 64.00% |
| 2008-03-30 | 62.19% |
| 2007-12-31 | 64.39% |
| 2007-09-30 | 61.98% |
| 2007-07-01 | 64.34% |
| 2007-04-01 | 65.18% |
| 2006-12-31 | 66.71% |
| 2006-10-01 | 69.41% |
| 2006-07-02 | 67.35% |
| 2006-04-02 | 68.07% |
| 2005-12-31 | 68.50% |
| 2005-10-02 | 66.19% |
| 2005-07-03 | 70.08% |
| 2005-04-03 | 69.64% |
| 2004-12-31 | 73.79% |
| 2004-10-03 | 73.97% |
| 2004-06-27 | 73.30% |
| 2004-03-28 | 74.06% |
| 2003-12-31 | 68.16% |
| 2003-09-28 | 67.50% |
| 2003-06-29 | 57.52% |
| 2003-03-30 | 55.33% |
| 2002-12-31 | 57.90% |
| 2002-09-29 | 67.67% |
